Roughly 1.1 million Medicare beneficiaries have signed up for access to discounted glucagon-like peptide-1 (GLP-1) medications through Medicare's Bridge program. Becker's Hospital Review reported the figure from an October 7, 2026, event where federal health official Chris Klomp discussed the program [1].
Eligible patients pay $50 for a monthly supply of certain drugs used for weight management. The Centers for Medicare & Medicaid Services (CMS) launched Medicare GLP-1 Bridge on July 1, 2026, and says it will run through December 31, 2027 [2].
Medicare open enrollment begins October 15, 2026 [3]. If you are considering weight-loss treatment, check your clinical eligibility and your prescription coverage before choosing next year's plan. Bridge has specific requirements, and ordinary Part D coverage still handles several other uses of these medications.
Who qualifies for Medicare GLP-1 Bridge?
You must be 18 or older, have an eligible form of Medicare prescription drug coverage, and meet one of three clinical routes. CMS uses your body mass index (BMI) when you started GLP-1 therapy [4].
BMI when treatment started | Additional condition required |
|---|---|
35 or higher | No additional condition required under this BMI route |
30 or higher | Heart failure with preserved ejection fraction, uncontrolled high blood pressure, or chronic kidney disease at stage 3a or higher |
27 or higher | Prediabetes, a previous heart attack, a previous stroke, or symptomatic peripheral artery disease |
All three routes also require a prescription for weight reduction or maintaining weight loss, alongside ongoing structured nutrition and physical activity [4].
CMS defines uncontrolled high blood pressure here as a top reading above 140 mm Hg or a bottom reading above 90 mm Hg, despite treatment with two blood-pressure medications. A hypertension diagnosis alone does not establish that criterion [4].
For example, someone who started treatment with a BMI of 32 and prediabetes may meet the BMI-27 route. Someone with a BMI of 32 and no qualifying additional diagnosis would not meet these clinical routes. Your prescriber must confirm the requirements and the appropriate coverage pathway [4].
Which Medicare plans qualify?
Eligible coverage includes a standalone Part D prescription drug plan or certain Medicare Advantage plans that include drug coverage. Medicare.gov also lists eligible Special Needs Plans, employer or union group waiver plans, and its temporary drug coverage program for newly eligible people with limited income [5].
Some other plan arrangements are excluded unless you also have an eligible standalone drug plan. Confirm your specific plan type with 1-800-MEDICARE (1-800-633-4227) [4].
Bridge operates separately from the usual Part D payment system. Part D insurers do not have to volunteer for the program for their eligible members to access it [2].
Why type 2 diabetes uses a different coverage pathway
CMS designed Bridge for weight management. People with type 2 diabetes, moderate-to-severe obstructive sleep apnea, or a qualifying form of metabolic dysfunction-associated steatohepatitis, an inflammatory liver disease with moderate-to-advanced scarring, must seek GLP-1 coverage through their Part D plan. CMS excludes them from Bridge even when they otherwise meet the BMI criteria [6].
That exclusion still applies if the plan does not cover the requested GLP-1. A coverage denial does not automatically make you Bridge-eligible [6].
The reason for the prescription also matters. A prescription intended to reduce major cardiovascular events belongs in Part D, even when weight management is another goal. Your prescriber should identify the correct route [6].
In 2026, CMS also checks whether you have already received a GLP-1 paid for through Part D during the calendar year. Prior covered use can make you ineligible for Bridge. CMS has not yet determined the lookback period it will apply in 2027 [6].
Which drugs does the $50 program cover?
CMS currently lists these products [2]:
Foundayo: tablets.
Wegovy: injections and tablets.
Zepbound: the KwikPen formulation only.
Bridge does not cover Zepbound's single-dose vials or single-dose pens. Pen needles for the KwikPen are also a separate purchase [4].
Ask your pharmacist to confirm the exact product and formulation before filling the prescription. The program's price does not apply to every medication commonly described as a GLP-1.
What the $50 copay does and does not include
Medicare.gov describes the charge as $50 for a one-month supply, which can be 28 or 30 days depending on the drug [5]. Twelve monthly payments would total $600, before other treatment expenses.
Because Bridge operates outside ordinary Part D coverage:
Your Part D deductible does not apply to the Bridge drug [2].
The $50 copay does not count toward your Part D annual out-of-pocket limit [5].
Extra Help, Medicare's assistance program for people with limited income and resources, does not lower the Bridge copay [5].
You cannot spread the charge across months through the Medicare Prescription Payment Plan [5].
Budget separately for appointments, any tests your clinician recommends, and supplies. The $50 price covers the medication furnished through Bridge; it does not describe your entire care bill.
How to get started
Start with the clinician who would prescribe the medication. Bring your Medicare information and records of your weight and relevant diagnoses when treatment began.
Your clinician sends a prescription for a covered product to your pharmacy and completes the program's prior authorization when requested. Prior authorization is the approval process that confirms whether you meet the coverage requirements [5].
Ask the office to check:
Whether your starting BMI and diagnoses meet a Bridge route.
Whether your prescription belongs in Bridge or ordinary Part D.
Whether previous Part D-paid GLP-1 use affects your eligibility.
Whether the pharmacy can process the exact formulation through Bridge.
If you have already lost weight on treatment, ask the prescriber to document your starting BMI. CMS allows eligibility based on the beginning of therapy, including treatment started before Bridge launched [4].
Medicare.gov says an approved authorization remains valid for refills and dose changes through December 31, 2027, unless you change GLP-1 medications. You can call 1-800-MEDICARE with eligibility questions or to check authorization status [5].
What to check during open enrollment
Medicare open enrollment runs October 15 through December 7, 2026. Plan changes generally take effect January 1, 2027 [3]. Bridge is already operating, so an eligible person with current drug coverage does not need to wait for that date to ask about treatment.
When comparing plans, review the whole year's care: premiums, your other prescriptions, participating pharmacies, and your doctors. If you need a GLP-1 for type 2 diabetes or another Part D-covered use, check the plan's covered drug list and approval rules for that use [6][3].
Free help is available through your State Health Insurance Assistance Program. Medicare's plan-comparison guidance recommends checking prescription coverage, networks, and annual costs together [3].
Sidebar: Walmart's $0 GLP-1 benefit has different rules
Walmart will introduce a $0 prescription tier on January 1, 2027, covering more than 250 medications [7].
Becker's reports that some GLP-1s will become free for eligible employees with type 2 diabetes, with a new prior authorization. Walmart confirmed that the coverage will still apply only to employees with that diagnosis in 2027 [8].
That is an employer benefit with different eligibility rules from Medicare Bridge. Employees seeking weight-loss treatment alone should confirm coverage rather than assume the $0 benefit applies.
Where your primary care doctor fits
A primary care membership does not determine Bridge eligibility. Your Medicare coverage, diagnoses, treatment history, and prescription determine the program's requirements.
If you already use a concierge or direct primary care (DPC) doctor, ask whether the office handles Bridge documentation and what it charges for follow-up. Our guide to ongoing primary care for GLP-1 patients covers the care relationship beyond the pharmacy bill.
Our concierge medicine guide for aging parents explains questions families should ask about membership fees and Medicare. If you are comparing concierge practices in Florida, including Naples Family Practice, confirm Medicare participation and authorization support directly with the office.
FAQ
Do all Medicare beneficiaries qualify for $50 GLP-1s?
No. You need an eligible drug-coverage arrangement, the required clinical criteria, and a prescription for the qualifying weight-management use. Other diagnoses and previous Part D-paid treatment can affect eligibility [4][6].
Can I qualify if my BMI is now below the threshold?
Potentially. CMS uses the criteria at the start of GLP-1 treatment. Your prescriber must document that you met them then [4].
Does the $50 copay count toward my Part D spending cap?
No. Bridge payments sit outside ordinary Part D, and the $50 charge does not count toward that annual limit [5].
You can find concierge and DPC doctors on NextMD. Before joining, ask how the practice works with Medicare and whether it can support your prescription and follow-up needs.
Sources
Casolo, E. (2026, October 13). 1.1 million Medicare beneficiaries signed up for GLP-1 Bridge model. Becker's Hospital Review. Read the Bridge signup report.
Centers for Medicare & Medicaid Services. (2026). Medicare GLP-1 Bridge. Read the program overview and payment rules.
Medicare.gov. (n.d.). Joining a plan. Read enrollment dates and plan-comparison guidance.
Centers for Medicare & Medicaid Services. (2026). Medicare GLP-1 Bridge: Information for Providers. Read clinical eligibility and prescribing requirements.
Medicare.gov. (2026). Weight loss drugs. Read patient eligibility, drug coverage, and copay details.
Centers for Medicare & Medicaid Services. (2026). Medicare GLP-1 Bridge: Information for Part D Plans. Read exclusions, prior-use rules, and Part D coverage distinctions.
Walmart. (2026, October 13). Keeping Affordable Healthcare Within Reach. Read Walmart's 2027 benefits announcement.
Casolo, E. (2026, October 13). Walmart makes some GLP-1s free for employees with Type 2 diabetes. Becker's Hospital Review. Read the GLP-1 benefit restrictions.

